Ajooni Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech Limited has informed NSE that the trading window for dealing in its securities will be closed for all officers, designated employees, and directors starting October 1, 2025. The closure is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. The window will remain shut until 48 hours after the company announces its unaudited financial results for the quarter and half-year ended September 30, 2025. This is a routine regulatory filing indicating that the Q2 FY26 results announcement is imminent.
This is a standard compliance announcement and has no direct impact on the stock price. However, it signals that the company's Q2 FY26 financial results are expected to be released soon, which investors should watch for as it may influence trading decisions.